Skip to content

In the BioHarmony Drug Report Database

Homatropine

Hydrocodone Bitartrate and Homatropine Methylbromide, NutropinAq (homatropine) is a small molecule pharmaceutical. Homatropine was first approved as Hydrocodone Bitartrate and Homatropine Methylbromide on 2001-02-15. It is used to treat inflammation in the USA. It has been approved in Europe to treat pituitary dwarfism, prader-willi syndrome, and turner syndrome.
Trade Name NutropinAq
Common Name Homatropine
Indication inflammation, pituitary dwarfism, prader-willi syndrome, turner syndrome
Drug Class Atropine derivatives
Homatropine
Get full access now